{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:18:48Z","timestamp":1790745528702,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009228","name":"Region \u00d6rebro l\u00e4n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The use of anti-B cell based therapies in immune-mediated diseases targeting general B cell markers or molecules important for B cell function has increased the clinical needs of monitoring B cell subpopulations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We analyzed the expression profile of cell surface markers CD86 and B and T lymphocyte attenuator (BTLA) in B cell subtypes using flow cytometry, including na\u00efve, transitional, switched memory, non-switched memory and double-negative memory B cells and plasmablasts, and investigated the dependence of age and sex in a healthy adult blood donor population. The switched memory B cell subtype displayed a divergent expression of the markers, with increased CD86 and decreased BTLA as compared to non-switched and double negative memory cells, as well as compared to na\u00efve B cells. Plasmablasts expressed highly increased CD86 compared to all other subtypes and a decreased expression of BTLA compared to na\u00efve cells, but still higher compared to the memory cell populations. Transitional B cells had CD86 and BTLA expression similar to the other na\u00efve cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We show divergent expression of CD86 and BTLA in memory cells and plasmablasts compared to na\u00efve B cells independent of age and sex. Furthermore, a similarly divergent difference of expression pattern was seen between the memory cell subtypes, altogether indicating that the combination of CD86 and BTLA might be markers for a permissive activation state. We suggest the combination of CD86 and BTLA expression on B cell subtypes as a potentially important tool in monitoring the status of B cell subtypes before and after treatments influencing the B cell compartment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12865-020-00343-2","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T12:02:59Z","timestamp":1584705779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex"],"prefix":"10.1186","volume":"21","author":[{"given":"Susanne","family":"Axelsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Magnuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Alshamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Hultgren","family":"H\u00f6rnquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Hultgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"issue":"1","key":"343_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1756285616666741","volume":"10","author":"S Bittner","year":"2017","unstructured":"Bittner S, Ruck T, H. wiendl H, et al. Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management. Ther Adv Neurol Disord. 2017;10(1):51\u201366 Review.","journal-title":"Ther Adv Neurol Disord"},{"issue":"11","key":"343_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1136\/annrheumdis-2017-211191","volume":"76","author":"MY Md Yusof","year":"2017","unstructured":"Md Yusof MY, Shaw D, El-Sherbiny YM, et al. Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. Ann Rheum Dis. 2017;76(11):1829\u201336.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"343_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"343_CR4","doi-asserted-by":"publisher","first-page":"19445","DOI":"10.18632\/oncotarget.4597","volume":"6","author":"S Kannan","year":"2015","unstructured":"Kannan S, Kurupati RK, Doyle SA, et al. BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine. Oncotarget. 2015;6(23):19445\u201355.","journal-title":"Oncotarget."},{"issue":"4","key":"343_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/QAI.0000000000000869","volume":"71","author":"LN Abudulai","year":"2016","unstructured":"Abudulai LN, Fernandez S, Corscadden K, et al. Chronic HIV-1 Infection Induces B-Cell Dysfunction That Is Incompletely Resolved by Long-Term Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2016;71(4):381\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5135","key":"343_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1126\/science.7694363","volume":"262","author":"GJ Freeman","year":"1993","unstructured":"Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science. 1993;262(5135):909\u201311.","journal-title":"Science."},{"issue":"2","key":"343_CR7","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/ar2985","volume":"12","author":"D Catal\u00e1n","year":"2010","unstructured":"Catal\u00e1n D, Aravena O, Sabugo F, et al. B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy. Arthritis Res Ther. 2010;12(2):R68.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"343_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.4049\/jimmunol.182.2.890","volume":"182","author":"KL Good","year":"2009","unstructured":"Good KL, Avery DT, Tangye SG. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol. 2009;182(2):890\u2013901.","journal-title":"J Immunol"},{"issue":"12","key":"343_CR9","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.4049\/jimmunol.0803783","volume":"183","author":"FC Rau","year":"2009","unstructured":"Rau FC, Dieter J, Luo Z, et al. B7-1\/2 (CD80\/CD86) direct signaling to B cells enhances IgG secretion. J Immunol. 2009;183(12):7661\u201371.","journal-title":"J Immunol"},{"key":"343_CR10","first-page":"762709","volume":"2015","author":"PW Zhao","year":"2015","unstructured":"Zhao PW, Ma L, Ji HF, et al. The expression of TLR-9, CD86, and CD95 phenotypes in circulating B cells of patients with chronic viral hepatitis B or C before and after antiviral therapy. Mediat Inflamm. 2015;2015:762709.","journal-title":"Mediat Inflamm"},{"key":"343_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3389\/fimmu.2018.01909","volume":"9","author":"A De Sousa Linhares","year":"2018","unstructured":"De Sousa Linhares A, Leitner J, Grabmeier-Pfistershammer K, et al. Not All Immune Checkpoints Are Created Equal. Front Immunol. 2018;9:1909 Review.","journal-title":"Front Immunol"},{"issue":"3","key":"343_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4049\/jimmunol.182.3.1509","volume":"182","author":"AC Vendel","year":"2009","unstructured":"Vendel AC, Calemine-Fenaux J, Izrael-Tomasevic A, et al. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK. J Immunol. 2009;182(3):1509\u201317.","journal-title":"J Immunol"},{"issue":"2","key":"343_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00109-012-0943-7","volume":"91","author":"ML Thibult","year":"2013","unstructured":"Thibult ML, Rivals JP, Mamessier E, et al. CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells. J Mol Med (Berl). 2013;91(2):195\u2013205.","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"343_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338 Review.","journal-title":"Nat Rev Immunol"},{"key":"343_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","volume":"33","author":"KL Flanagan","year":"2017","unstructured":"Flanagan KL, Fink AL, Plebanski M, et al. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. Annu Rev Cell Dev Biol. 2017;33:577\u201399 Review.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"343_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/nicc.12280","volume":"22","author":"E Papathanassoglou","year":"2017","unstructured":"Papathanassoglou E, Middleton N, Benbenishty J, et al. Systematic review of gender- dependent outcomes in sepsis. Nurs Crit Care. 2017;22(5):284\u201392 Review.","journal-title":"Nurs Crit Care"},{"issue":"26","key":"343_CR17","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1182\/blood-2012-12-471953","volume":"121","author":"K Covens","year":"2013","unstructured":"Covens K, Verbinnen B, Geukens N, et al. Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype. Blood. 2013;121(26):5176\u201383.","journal-title":"Blood."},{"issue":"11","key":"343_CR18","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","volume":"105","author":"GPS GP","year":"2005","unstructured":"GP GPS, R. Ettinger R, Shirota Y, et al. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390\u20138.","journal-title":"Blood"},{"issue":"10","key":"343_CR19","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.4049\/jimmunol.0801859","volume":"182","author":"A Palanichamy","year":"2009","unstructured":"Palanichamy A, Barnard J, Zheng B, et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009;182(10):5982\u201393.","journal-title":"J Immunol"},{"issue":"1","key":"343_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cei.12149","volume":"174","author":"S Agrawal","year":"2013","unstructured":"Agrawal S, Smith SA, Tangye SG, et al. Transitional B cell subsets in human bone marrow. Clin Exp Immunol. 2013;174(1):53\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"343_CR21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4049\/jimmunol.165.2.680","volume":"165","author":"DJ Kasprowicz","year":"2000","unstructured":"Kasprowicz DJ, Kohm AP, Berton MT, et al. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J Immunol. 2000;165(2):680\u201390.","journal-title":"J Immunol"},{"key":"343_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fimmu.2012.00078","volume":"3","author":"K Fink","year":"2012","unstructured":"Fink K. Origin and Function of Circulating Plasmablasts during Acute Viral Infections. Front Immunol. 2012;3:78.","journal-title":"Front Immunol"},{"key":"343_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fimmu.2018.00626","volume":"9","author":"F Hu","year":"2018","unstructured":"Hu F, Zhang W, Shi L, et al. Impaired CD27+IgD+ B Cells With Altered Gene Signature in Rheumatoid Arthritis. Front Immunol. 2018;9:626.","journal-title":"Front Immunol"},{"issue":"11","key":"343_CR24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1086\/516788","volume":"195","author":"D van Duin","year":"2007","unstructured":"van Duin D, Allore HG, Mohanty S, et al. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis. 2007;195(11):1590\u20137.","journal-title":"J Infect Dis"},{"key":"343_CR25","doi-asserted-by":"publisher","first-page":"305656","DOI":"10.1155\/2011\/305656","volume":"2011","author":"M Oki","year":"2011","unstructured":"Oki M, Watanabe N, Owada T, et al. A functional polymorphism in B and T lymphocyte attenuator is associated with susceptibility to rheumatoid arthritis. Clin Dev Immunol. 2011;2011:305656.","journal-title":"Clin Dev Immunol"},{"key":"343_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-2094-11-18","volume":"11","author":"SM Menezes","year":"2014","unstructured":"Menezes SM, Decanine D, Brassat D, et al. CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy\/tropical spastic paraparesis and multiple sclerosis. J Neuroinflammation. 2014;11:18.","journal-title":"J Neuroinflammation"},{"key":"343_CR27","doi-asserted-by":"publisher","unstructured":"Smets I, Fiddes B, Garcia-Perez JE, et al. Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells. Brain. 2018;18. https:\/\/doi.org\/10.1093\/brain\/awx372 [Epub ahead of print].","DOI":"10.1093\/brain\/awx372"},{"key":"343_CR28","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65\u201370.","journal-title":"Scand J Stat"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-020-00343-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-020-00343-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-020-00343-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:23:53Z","timestamp":1616199833000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-020-00343-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s12865-020-00343-2","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"assertion":[{"value":"21 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were informed with a written description of the aims of the study and provided an oral consent to participate. The blood sample were made anonymous and the only information kept was gender and age (<\u200941\u2009years or\u2009\u2265\u200941\u2009years). Informed consent was obtained from all participants. Approval from ethics committee was not applicable, according to the Swedish Act concerning the Ethical Review of Research Involving Humans (2003:460).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}